| License: Creative Commons Attribution 4.0 PDF - Published Version (787kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-537408
- DOI to cite this document:
- 10.5283/epub.53740
Abstract
BackgroundPatients with COVID-19 and severe acute respiratory failure may require veno-venous extracorporeal membrane oxygenation (VV ECMO). Yet, this procedure is resource-intensive and high mortality rates have been reported. Thus, predictors for identifying patients who will benefit from VV ECMO would be helpful. MethodsThis retrospective study included 129 patients with COVID-19 and severe ...

Owner only: item control page

Download Statistics